NuWays reiterates Buy on Hoenle, sets EUR 14 price target

• NuWays reiterated a BUY rating on Hönle, setting a 12-month target price of EUR 14.
• Q3 FY25/26 EBITDA rose 54.3% to EUR 1.7 million; revenue increased 4.6% to EUR 23.7 million.
• Adhesive Solutions drove the beat, with EBITDA more than tripling to EUR 1.71 million; revenue climbed 17.5% to EUR 9.2 million.
• Curing stayed loss-making with EBITDA of EUR -0.8 million; revenue fell 19.6% to EUR 7 million on weak investment demand.
• Disinfection sales grew 22.8% to EUR 7.5 million; EBITDA improved 26.3% to EUR 0.8 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hönle AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_26580) on August 19, 2026, and is solely responsible for the information contained therein.